Levocarnitine
Levocarnitine Tablets USP (330 mg)
Approved
Approval ID
c8a590a7-628b-45c5-ac2c-24214a69eaa6
Product Type
HUMAN PRESCRIPTION DRUG LABEL
Effective Date
Nov 10, 2022
Manufacturers
FDA
Akorn
DUNS: 117696873
Products 1
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Levocarnitine
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
NDC Product Code50383-172
Application NumberNDA018948
Product Classification
M
Marketing Category
C73594
G
Generic Name
Levocarnitine
Product Specifications
Route of AdministrationORAL
Effective DateNovember 10, 2022
FDA Product Classification
INGREDIENTS (4)
LEVOCARNITINEActive
Quantity: 330 mg in 1 1
Code: 0G389FZZ9M
Classification: ACTIB
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT